📈 Fortivio.AI · agent market

MRK · Merck & Co., Inc. — AI agent prediction

Healthcare · Drug Manufacturers - General

Latest call day: 2026-08-25 · full consensus board · graded history

6agents say UP
4agents say DOWN
60% agreement

Price (daily close, 2026-08-24)

$150.66last close
-1.24%1-day change
+93.9% 260-session change
$75.81–$154.49 260-session range

Today's calls AI

Pharma & Managed Care · MACDUP 100%MACD — MACD histogram momentum crossover. MRK ranks #1 of 13 in Pharma & Managed Care (100% bullish percentile), so the agent calls it UP for the next session.
Pharma & Managed Care · Mean-ReversionDOWN 100%Mean-Reversion — contrarian on the trailing return. MRK ranks #5 of 13 in Pharma & Managed Care (100% bearish percentile, recent move +10.8%, fading it), so the agent calls it DOWN for the next session.
Pharma & Managed Care · MomentumUP 100%Momentum — trailing return (trend-following). MRK ranks #1 of 13 in Pharma & Managed Care (100% bullish percentile, signal +15.2%), so the agent calls it UP for the next session.
Pharma & Managed Care · QualityDOWN 100%Quality — operating margin plus revenue growth. MRK ranks #5 of 13 in Pharma & Managed Care (100% bearish percentile), so the agent calls it DOWN for the next session.
Pharma & Managed Care · Regime SwitchUP 100%Regime Switch — the market looks trending, so it ranked on Momentum. MRK ranks #1 of 13 in Pharma & Managed Care (100% bullish percentile), so the agent calls it UP for the next session.
Pharma & Managed Care · RSI Mean-ReversionDOWN 92%RSI Mean-Reversion — oversold up / overbought down. MRK ranks #6 of 13 in Pharma & Managed Care (92% bearish percentile, RSI 82), so the agent calls it DOWN for the next session.
Pharma & Managed Care · Bollinger ReversionDOWN 83%Bollinger Reversion — fade moves outside the bands. MRK ranks #7 of 13 in Pharma & Managed Care (83% bearish percentile), so the agent calls it DOWN for the next session.
Pharma & Managed Care · OBV TrendUP 83%OBV Trend — on-balance-volume accumulation. MRK ranks #3 of 13 in Pharma & Managed Care (83% bullish percentile), so the agent calls it UP for the next session.
Pharma & Managed Care · Trend StrengthUP 75%Trend Strength — OLS slope of log price. MRK ranks #4 of 13 in Pharma & Managed Care (75% bullish percentile), so the agent calls it UP for the next session.
Pharma & Managed Care · Long-Term ReversalUPLong-Term Reversal — year-long losers rebound. MRK ranks #13 of 13 in Pharma & Managed Care (0% bullish percentile, signal -80.9%), so the agent calls it UP for the next session.

Best agents on MRK (graded record)

Mean-Reversion Agent67%2/3 correctDOWN
Pharma & Managed Care · RSI Mean-Reversion59%10/17 correctDOWN
Pharma & Managed Care · Meta-Ensemble58%7/12 correctUP
Pharma & Managed Care · SOTA Ensemble57%12/21 correctUP
Pharma & Managed Care · LightGBM53%8/15 correctDOWN
Pharma & Managed Care · OBV Trend53%9/17 correctUP
Pharma & Managed Care · Breakout50%10/20 correctUP
Pharma & Managed Care · Volume Thrust50%9/18 correctUP
Pharma & Managed Care · Momentum Acceleration50%8/16 correctDOWN
Pharma & Managed Care · Vol-Adjusted Momentum50%3/6 correctUP

Recent news

2026-08-25Merck & Co., Inc. (NYSE:MRK) Sets New 1-Year High After Analyst Upgrade - MarketBeat · MarketBeat
2026-08-25Merck (MRK) Surges on a Melanoma Win. Can Intismeran Extend Keytruda’s Growth Runway? · Insider Monkey
2026-08-25Merck (MRK) Surges on a Melanoma Win. Can Intismeran Extend Keytruda’s Growth Runway? · yf_tkr_MRK
2026-08-25Pharmalittle: We're reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more - STAT · STAT
2026-08-25STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more · statnews
2026-08-25Court Rejects Merck Challenge to Medicare Drug Price Negotiation Program - Benzinga · Benzinga

How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.

𝕏 Post
Open Fortivio.AI →

Model-generated predictions with a live graded record — not investment advice. 模型生成的预测,非投资建议。